BRCA2 mutations have significant public health implications due to their association with increased cancer risk. Identifying carriers through genetic testing can lead to early interventions and reduced cancer incidence. Public health initiatives often focus on raising awareness, providing access to genetic counseling, and supporting research efforts.
